Conference Coverage
Conference Coverage
Delaying cancer treatment for fertility preservation did not affect outcomes
SALT LAKE CITY – Delaying cancer treatment for fertility preservation did not affect long-term cancer outcomes, suggest the findings from a...
Conference Coverage
Women recovered half their ovarian reserve 13 months after chemotherapy
SALT LAKE CITY
Conference Coverage
FALCON airs PFS edge for fulvestrant in ER+ breast cancer
The selective estrogen receptor degrader fulvestrant continues to offer improved progression-free survival compared with the aromatase inhibitor...
Conference Coverage
Ribociclib/letrozole combo a ‘game changer’ in advanced breast cancer
COPENHAGEN – Progression-free survival for postmenopausal women with hormone receptor–positive advanced breast cancer was significantly improved...
Conference Coverage
Partial-breast irradiation alternative to mastectomy following recurrence
BOSTON – In women with in-breast failures following breast-conserving surgery and whole-breast irradiation, partial-breast irradiation with 3D...
Conference Coverage
Boost dose pays off long term after surgery, WBRT for DCIS
BOSTON – Adding a boost dose after surgery and whole-breast radiation therapy (WBRT) for ductal carcinoma in situ offers a small but significant...
Conference Coverage
New data shed light on impact of resecting the primary tumor in stage IV breast cancer
Key clinical point: Resecting the primary tumor up front had a survival benefit, whereas resecting it after a response to systemic therapy did not...
Conference Coverage
Safety of sentinel node dissection alone holds up a decade out
Key clinical point: In women with clinical early-stage breast cancer who have a positive sentinel node and undergo breast-conserving therapy,...
Conference Coverage
Adjuvant AI therapy for breast cancer: 10 years is superior to 5 years
Extending adjuvant aromatase inhibitor (AI) therapy from 5 years to 10 years further reduces the risk of recurrence and new breast cancer in...
Conference Coverage
Liquid biopsies prove useful alternative to tissue biopsies
Liquid biopsy, the testing of the blood for circulating tumor DNA (ctDNA), identified cancer mutations useful as biomarkers – many associated with...